| Literature DB >> 27758857 |
Jenna K Zalewski1, Joshua H Mo1, Simone Heber1, Annie Heroux2, Richard G Gardner3, Jeffrey D Hildebrand1, Andrew P VanDemark4.
Abstract
Shroom-mediated remodeling of the actomyosin cytoskeleton is a critical driver of cellular shape and tissue morphology that underlies the development of many tissues including the neural tube, eye, intestines, and vasculature. Shroom uses a conserved SD2 domain to direct the subcellular localization of Rho-associated kinase (Rock), which in turn drives changes in the cytoskeleton and cellular morphology through its ability to phosphorylate and activate non-muscle myosin II. Here, we present the structure of the human Shroom-Rock binding module, revealing an unexpected stoichiometry for Shroom in which two Shroom SD2 domains bind independent surfaces on Rock. Mutation of interfacial residues impaired Shroom-Rock binding in vitro and resulted in altered remodeling of the cytoskeleton and loss of Shroom-mediated changes in cellular morphology. Additionally, we provide the first direct evidence that Shroom can function as a Rock activator. These data provide molecular insight into the Shroom-Rock interface and demonstrate that Shroom directly participates in regulating cytoskeletal dynamics, adding to its known role in Rock localization.Entities:
Keywords: Ras homolog gene family, member A (RhoA); Rho-kinase; RhoA; Shroom; X-ray crystallography; coiled-coil; cytoskeleton; serine/threonine protein kinase; structural biology
Mesh:
Substances:
Year: 2016 PMID: 27758857 PMCID: PMC5207239 DOI: 10.1074/jbc.M116.738559
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157